T1	Participants 93 124	people with multiple sclerosis.
T2	Participants 216 246	people with multiple sclerosis
T3	Participants 426 445	multiple sclerosis.
T4	Participants 500 586	In phase 1, 36 participants were randomly assigned to experimental and control groups.
T5	Participants 590 616	phase 2, the control group
T6	Participants 1658 1693	people with multiple sclerosis (MS)
